Revolution in the fight against autoimmune diseases: Granite Bio debuts with $100 million of capital
Breakthrough antibody therapies target the roots of inflammation and promise breakthroughs for millions of patients
Spotlight on life sciences start-ups
Biotechnology
Granite Bio AG
Granite Bio is a biotechnology company developing first-in-class antibodies that target the root causes of a variety of inflammatory, autoimmune and fibrotic conditions. Granite is backed by leading healthcare venture firms including Versant Ventures, Novartis Venture Fund, Forbion and Sanofi ...
View start-up
Biotechnology
ESTER Biotech GmbH
ESTER Biotech is a Spin-Off of Leipzig University and its idea was born in the Biocity of Leipzig in 2022. We believe that enzymatic recycling will fundamentally change plastic waste management. By breaking down plastics at a molecular level, enzymes enable a truly circular economy. They ...
View start-up
Diagnostics
Chemeleon
Chemeleon has created a novel platform technology for rapid, accurate, and affordable diagnostics that are capable of detecting a broad range of analytes including drugs, proteins, and viruses. This proprietary, sample-to-answer format provides a colorimetric readout in minutes, visible to the ...
View start-upStart-ups by industry
Loading...
Start-up News
Life sciences start-ups by country
More start-ups from other industries
Loading...